Urology Surgery Supplies Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Urology Surgical Supplies Market is Segmented by Product Type (Endoscopes, Energy/Lithotripsy, Stone Management, Catheters, Stents, and Biopsy), Technology (Minimally Invasive, Robotic Surgery, and Laser-Based), Application (Kidney Stones, BPH, and More), End User (Hospitals, Ascs, Specialty Clinics, and Other), and Geography (North America, Europe, Asia-Pacific, MEA, and South America). Forecasts are in Value (USD).

Urology Surgery Supplies Market Size and Share

Urology Surgery Supplies Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Urology Surgery Supplies Market Analysis by Mordor Intelligence

The Urology Surgery Supplies Market size is projected to expand from USD 3.96 billion in 2026 and USD 4.25 billion in 2027 to USD 6.05 billion by 2032, registering a CAGR of 7.32% between 2027 and 2032.

Procedure demand is expanding across stone disease, cancer surgery, and benign prostatic hyperplasia care, where minimally invasive techniques require specialized instruments and recurring supplies. A 2025 meta-analysis reported global urolithiasis prevalence of 10.85%, which supports continued demand for treatment equipment and procedure consumables. The movement of procedures from inpatient facilities to ambulatory surgery centers and office settings is changing purchasing toward ready-to-use, single-use supplies. Suppliers are responding through integrated platforms that combine visualization, laser treatment, irrigation, and pressure monitoring. Competitive opportunities are expanding where manufacturers can demonstrate clinical outcomes, efficient workflows, and regulatory compliance.

Key Report Takeaways

  • By product type, endoscopes and visualization systems held 38.65% of the urology surgical supplies market share in 2026, while Stone Management accessories are forecast to grow at a 9.64% CAGR through 2032.
  • By technology, minimally invasive technology accounted for 47.65% of the urology surgical supplies market share in 2026, while laser-based solutions are forecast to grow at a 9.99% CAGR through 2032.
  • By application, kidney stones and urolithiasis held 37.54% of the urology surgical supplies market share in 2026, while urological cancer is forecast to grow at a 10.55% CAGR through 2032.
  • By end user, hospitals accounted for 43.54% of the urology surgical supplies market share in 2026, while specialty urology clinics are forecast to grow at a 10.67% CAGR through 2032.
  • By geography, North America held 42.76% of the urology surgical supplies market share in 2026, while Asia-Pacific is forecast to grow at an 8.54% CAGR through 2032.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Urology Surgery Supplies Market Segment Analysis

By Product Type:

Visualization Platforms Anchor Spending, Accessories Drive Growth

Endoscopes and visualization systems held 38.65% of the urology surgical supplies market share in 2026. Their position reflects the importance of flexible cystoscopes and digital ureteroscopes in diagnostic and therapeutic procedures. These systems are supported by a large installed base and recurring replacement needs. Olympus launched the VISERA S OTV-S500 imaging platform in the United States in September 2025. The platform includes Narrow Band Imaging for urology applications. Procurement decisions increasingly weigh imaging capabilities against downstream clinical and workflow outcomes. Visualization remains a core spending category across hospitals, ambulatory centers, and specialty clinics.

Stone management accessories are forecast to grow at a 9.64% CAGR through 2032. Each flexible ureteroscopy case can require a retrieval basket, access sheath, and guidewire. This creates recurring demand that is less dependent on capital replacement cycles. Catheters and tubes remain high-volume products but face price pressure from group purchasing organizations. China’s sixth national procurement cycle included ureteral stents and stone retrieval accessories in January 2026. Stents and implants are becoming more differentiated through long-dwell alloy designs, while standard polymer devices face greater pricing pressure. ISO 13485:2016 and FDA 21 CFR Part 820 requirements remain important compliance factors for sterility and quality management.

Need more granular breakdown of segment shares?

Get tailored market insights for your requirements.

Urology Surgery Supplies Market Share by Product Type, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Urology Surgery Supplies Market Share by Product Type, 2026

By Technology:

Minimally Invasive Care Establishes the Baseline, Lasers Redefine the Ceiling

Minimally invasive technology accounted for 47.65% of the urology surgical supplies market share in 2026. It is now the established approach for stone disease, benign prostatic hyperplasia, and many early-stage urological cancers. Open surgery remains relevant for complex multi-organ resections, but it has a narrower role in routine procedures. Intuitive Surgical reported 20% year-over-year global da Vinci procedure growth in the third quarter of 2025. Urology accounted for 43.2% of NHS robotic procedures in 2024. Medtronic’s FDA clearance for Hugo increases platform competition and adds potential demand for compatible instruments.

Laser-based solutions are forecast to grow at a 9.99% CAGR through 2032. Thulium fiber laser technology has shown a higher stone-free rate and shorter operative time than holmium:YAG in randomized trial evidence. High acquisition costs remain a barrier for low-volume centers. Olympus launched the SOLTIVE Gemini 60W Thulium Fiber Laser System in the United States in November 2026. The system includes StoneSense technology, which stops emission when the fiber is not aimed at a stone. This reflects a shift toward technology that links treatment performance with safety features. EU MDR 2017/745 post-market surveillance requirements influence documentation and product design for European laser suppliers.

By Application:

Kidney Stones Lead the Volume, Oncology Leads the Growth

Kidney stones and urolithiasis held 37.54% of the urology surgical supplies market share in 2026. The category is supported by disease prevalence above 10% worldwide. Asia and the Middle East and North Africa have particularly high pooled prevalence. Stone procedures require endoscopic visualization, lithotripsy, baskets, guidewires, access sheaths, and stents. Benign prostatic hyperplasia remains a high-volume use case. Treatment is shifting toward minimally invasive surgical therapies, including UroLift, water vapor ablation, and prostatic artery embolization. Ureteral stricture and obstruction treatment also relies on guidewires, dilators, and stents that overlap with stone-care supply needs.

Urological cancer is forecast to grow at a 10.55% CAGR through 2032. Robotic prostatectomy, nephrectomy, and cystectomy are supporting demand for advanced surgical platforms and instruments. In May 2026, Virtuoso Surgical received FDA De Novo authorization for a robotic system designed for transurethral en bloc bladder lesion excision. The FDA also proposed moving blue-light cystoscopy systems from Class III to Class II in August 2026. If finalized, the change could reduce barriers to entry in fluorescence-guided bladder cancer detection. Other applications include urinary incontinence management through neuromodulation devices. Boston Scientific’s acquisition of Valencia Technologies added the eCoin implantable tibial nerve stimulation system to its pelvic health portfolio.

Segment this market the way your business does.

Get tailored market insights for your requirements.

Urology Surgery Supplies Market Share by Application, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By End User:

Hospitals Anchor the Core, Outpatient Clinics Accelerate the Frontier

Hospitals accounted for 43.54% of the urology surgical supplies market share in 2026. They remain the primary sites for capital-intensive robotics, complex cancer surgery, and high-acuity stone treatment. General anesthesia capacity and integrated imaging support these cases. Hospital value analysis committees increasingly compare clinical outcomes, infection metrics, and total procedure costs. This favors suppliers with peer-reviewed evidence and robust service support. Higher-acuity procedures also require a broader range of disposable and reusable supplies. Hospitals therefore remain central to platform adoption and procedure-based demand.

Specialty urology clinics are forecast to grow at a 10.67% CAGR through 2032. Their growth reflects more dedicated outpatient infrastructure in North America, Western Europe, and parts of Asia-Pacific. These settings often benefit from single-use products because they lack large central sterilization departments. U.S. News evaluated 708 urology-focused ambulatory surgery centers in its 2025 ranking process. The recognition of high-performing centers shows that outpatient urology has become an important care setting. Ambulatory centers are also gaining procedural complexity as policy supports site-of-care migration. Diagnostic centers and long-term care facilities continue to create steady demand for catheter and continence management supplies.

Geography Analysis

North America: Installed-Base Depth Meets Regulatory Momentum

North America held 42.76% of the urology surgical supplies market share in 2026. The urology surgical supplies market in the region benefits from high robotic procedure volume, broad single-use adoption, and rapid product launches. CMS policy changes in 2026 support the movement of selected procedures into outpatient settings. Medtronic completed the first U.S. commercial Hugo procedure at Cleveland Clinic in February 2026 after the platform’s earlier clearance. The entry expands robotic options for hospitals. The FDA also cleared Boston Scientific’s Asurys Fluid Management System in March 2026. Canada is adding robotic capacity through provincial hospitals, while Mexico’s private networks are adopting flexible ureteroscopy and laser lithotripsy. Budget limits remain important in public procurement systems.

Asia-Pacific: Demographic Demand Meets Manufacturing Ambition

Asia-Pacific is forecast to grow at an 8.54% CAGR through 2032. The urology surgical supplies market in Asia-Pacific is supported by China and India’s expanding care infrastructure, while Japan’s aging population supports demand for treatment of benign prostatic hyperplasia and urological malignancies. China’s national procurement system is reshaping prices for stents and stone-management accessories. The sixth national procurement cycle selected 440 products from 170 companies in January 2026. Domestic manufacturers are also expanding their export ambitions in single-use ureteroscopes. Japan has a substantial installed base of da Vinci systems and approved domestic robotic alternatives. South Korea supports premium technology adoption, while India’s tier-2 city hospitals are increasing procedure capacity. Regulatory influence from the PMDA and national procurement rules will shape product access and pricing across the region.

Europe, MEA, and South America: Structural Diversity Shapes Device Strategies

Europe has advanced urology services, but reimbursement differences create varied device demand. A German micro-costing study found reusable cystoscopes cost EUR 27.25 per procedure, compared with EUR 179.00 for single-use devices, with reusable systems becoming cost-effective above 67 annual procedures. The EAU’s 2025 urolithiasis guideline provides a common clinical reference for flexible ureteroscopy and laser treatment. MEA has high stone disease prevalence, but advanced device penetration remains concentrated in GCC countries. South America’s private hospital networks in Brazil and Argentina are using single-use endoscopes and laser lithotripsy. Public systems in the region remain more reliant on reusable instruments and ESWL. This difference requires suppliers to offer both premium platforms and value-based product lines. EU MDR requirements add further compliance obligations for device manufacturers serving Europe.

Urology Surgery Supplies Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market Concentration

Urology Surgery Supplies Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The urology surgical supplies market is moderately concentrated at the platform level and more fragmented in consumables. Boston Scientific, Olympus, Intuitive Surgical, Medtronic, and KARL STORZ hold significant positions across major categories. Cook Medical, Coloplast, Dornier MedTech, Ambu, Richard Wolf, and Stryker also compete in selected product areas. Intuitive Surgical maintains a leading robotic position through the da Vinci platform. Olympus and KARL STORZ compete in visualization through imaging and fluorescence technologies. Boston Scientific combines stone management, endoscopy, continence, and pelvic health products. Product portfolios are increasingly built around complete procedure pathways rather than individual devices.

Teleflex announced in December 2025 that it would sell its Acute Care, Interventional Urology, and OEM businesses to Intersurgical for USD 2.03 billion[2]. The transaction reshapes competition in catheter management and benign prostatic hyperplasia products. Boston Scientific completed its acquisition of Valencia Technologies in April 2026, adding eCoin therapy for urge urinary incontinence. Olympus launched an AI-powered surgical planning tool with Ziosoft in March 2025 for kidney procedure planning. These moves show a focus on portfolio breadth, procedural data, and clinical workflow support. Medtronic’s Hugo platform similarly combines robotic hardware with the Touch Surgery digital ecosystem.

Chinese manufacturers are increasing participation in single-use ureteroscope development and FDA filing activity. This can create value-segment competition in Western markets. Incumbents are differentiating through pressure monitoring, suction, connectivity, imaging, and training support. The proposed FDA reclassification of blue-light cystoscopy could lower entry barriers if it is finalized. ISO 13485 and EU MDR 2017/745 keep quality management and post-market surveillance demanding for new entrants. These requirements can limit entry by smaller companies despite easier pathways in some categories.

Urology Surgery Supplies Industry Leaders

  1. Boston Scientific Corporation

  2. Olympus Corporation

  3. Medtronic plc

  4. Becton, Dickinson and Company

  5. Fresenius Medical Care AG and Co. KGaA

  6. *Disclaimer: Major Players sorted in no particular order

Urology Surgery Supplies Market Companies Covered in this Report

  • B. Braun
  • Baxter
  • Beckton Dickinson
  • Boston Scientific
  • Coloplast
  • Conmed
  • Convatec Group plc
  • Cook Group
  • Dornier MedTech
  • Intuitive Surgical, Inc.
  • Karl Storz
  • Laborie
  • Medtronic
  • Olympus
  • Richard Wolf
  • Siemens Healthineers
  • Stryker
  • Teleflex
  • Urotech GmbH

Recent Industry Developments in Urology Surgery Supplies Market

  • November 2026: Olympus launched the SOLTIVE Gemini 60W Thulium Fiber Laser System in the United States, featuring StoneSense technology that automatically stops laser emission when the surgical fiber is not aimed at a stone. The platform offers 6 pulse modes for stone and soft tissue procedures, positioning it broadly across stone-to-oncology applications.
  • May 2026: Verathon launched CFlex, an FDA 510(k)-cleared single-use flexible cystoscope, in the United States, entering the urology visualization segment.
  • April 2026: Boston Scientific completed its acquisition of Valencia Technologies, adding the FDA-approved eCoin implantable tibial nerve stimulation system for urge urinary incontinence.
  • March 2026: Boston Scientific received FDA 510(k) clearance for the Asurys Fluid Management System, which regulates irrigation inflow during ureteroscopy using intrarenal pressure data when paired with the LithoVue Elite ureteroscope.

Table of Contents for Urology Surgery Supplies Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence and Recurrence of Urolithiasis
    • 4.2.2 Shift Toward Minimally Invasive Urologic Procedures
    • 4.2.3 Expansion of Ambulatory and Office-Based Urology
    • 4.2.4 Single-Use Endoscopy and Infection-Control Economics
    • 4.2.5 Integrated Laser, Irrigation, and Intrarenal Pressure Management
    • 4.2.6 Climate-Linked Dehydration and Stone Recurrence Risk
  • 4.3 Market Restraints
    • 4.3.1 High Capital and Procedure Costs for Advanced Platforms
    • 4.3.2 Shortage of Endourology Specialists and Operating-Room Technicians
    • 4.3.3 Reprocessing, Waste, and Sustainability Burden
    • 4.3.4 Low Utilization and Replacement Delays for Capital-Intensive ESWL Systems
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat Of New Entrants
    • 4.7.2 Bargaining Power Of Buyers
    • 4.7.3 Bargaining Power Of Suppliers
    • 4.7.4 Threat Of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Endoscopes and Visualization Systems
    • 5.1.2 Energy and Lithotripsy Systems
    • 5.1.3 Stone Management Accessories
    • 5.1.4 Catheters and Tubes
    • 5.1.5 Stents and Implants
    • 5.1.6 Biopsy and Diagnostic Supplies
  • 5.2 By Technology
    • 5.2.1 Minimally invasive technology
    • 5.2.2 Robotic surgery systems
    • 5.2.3 Laser-based solutions
  • 5.3 By Application
    • 5.3.1 Kidney Stones and Urolithiasis
    • 5.3.2 Benign Prostatic Hyperplasia
    • 5.3.3 Urological Cancer
    • 5.3.4 Ureteral Strictures and Obstruction
    • 5.3.5 Other Application
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgery Centers
    • 5.4.3 Specialty Urology Clinics
    • 5.4.4 Other End User
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(Includes Global Level Overview, Market Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)}
    • 6.3.1 B. Braun SE
    • 6.3.2 Baxter International Inc.
    • 6.3.3 Becton, Dickinson and Company
    • 6.3.4 Boston Scientific Corporation
    • 6.3.5 Coloplast A/S
    • 6.3.6 CONMED Corporation
    • 6.3.7 Convatec Group plc
    • 6.3.8 Cook Medical LLC
    • 6.3.9 Dornier MedTech GmbH
    • 6.3.10 Intuitive Surgical, Inc.
    • 6.3.11 KARL STORZ SE and Co. KG
    • 6.3.12 Laborie Medical Technologies Corp.
    • 6.3.13 Medtronic plc
    • 6.3.14 Olympus Corporation
    • 6.3.15 Richard Wolf GmbH
    • 6.3.16 Siemens Healthineers AG
    • 6.3.17 Stryker Corporation
    • 6.3.18 Teleflex Incorporated
    • 6.3.19 Urotech GmbH

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment

Global Urology Surgery Supplies Market Report Scope

According to the report’s scope, urology surgery supplies are medical devices and consumables used to diagnose and treat conditions affecting the urinary tract and male reproductive system. They include instruments, catheters, scopes, stents, guidewires, and surgical accessories used in open, endoscopic, and minimally invasive procedures.

The urology surgery supplies market is segmented into product type, technology, application, end user, and geography. By product type, the market is segmented into Endoscopes, Energy/Lithotripsy, Stone Management, Catheters, Stents, and Biopsy. By technology, the market is segmented into Minimally Invasive, Robotic Surgery, and Laser-Based. By application, the market is segmented into kidney stones, BPH, cancer, ureteral strictures, and other.  By end user, the market is segmented into hospitals, ASCs, specialty clinics, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values (USD) for all the above segments.  

Segmentation Overview

By Product Type
Urology Surgery Supplies Market segmentation breakdown
Endoscopes and Visualization Systems
Energy and Lithotripsy Systems
Stone Management Accessories
Catheters and Tubes
Stents and Implants
Biopsy and Diagnostic Supplies
By Technology
Urology Surgery Supplies Market segmentation breakdown
Minimally invasive technology
Robotic surgery systems
Laser-based solutions
By Application
Urology Surgery Supplies Market segmentation breakdown
Kidney Stones and Urolithiasis
Benign Prostatic Hyperplasia
Urological Cancer
Ureteral Strictures and Obstruction
Other Application
By End User
Urology Surgery Supplies Market segmentation breakdown
Hospitals
Ambulatory Surgery Centers
Specialty Urology Clinics
Other End User
Geography
Urology Surgery Supplies Market segmentation breakdown
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Urology Surgery Supplies Market segmentation breakdown
By Product Type Endoscopes and Visualization Systems
Energy and Lithotripsy Systems
Stone Management Accessories
Catheters and Tubes
Stents and Implants
Biopsy and Diagnostic Supplies
By Technology Minimally invasive technology
Robotic surgery systems
Laser-based solutions
By Application Kidney Stones and Urolithiasis
Benign Prostatic Hyperplasia
Urological Cancer
Ureteral Strictures and Obstruction
Other Application
By End User Hospitals
Ambulatory Surgery Centers
Specialty Urology Clinics
Other End User
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America

Key Questions Answered in the Report

What is driving growth in urology surgical supplies?

Growing stone disease prevalence, more minimally invasive procedures, and the move to outpatient care are supporting demand. The report projects a 7.32% CAGR through 2032.

Which product category has the largest share?

Endoscopes and Visualization Systems held 38.65% share in 2026, supported by their role in diagnostic and therapeutic procedures.

Which technology is growing fastest in urology procedures?

Laser-Based Solutions are forecast to grow at a 9.99% CAGR through 2032, supported by thulium fiber laser adoption.

Why are single-use ureteroscopes gaining adoption?

Infection-control requirements, simpler workflows, and reduced reprocessing needs are increasing their use, especially in outpatient settings.

Which end-user setting is growing fastest?

Specialty Urology Clinics are projected to expand at a 10.67% CAGR through 2032 as outpatient infrastructure develops.

Which region is projected to grow fastest?

Asia-Pacific is forecast to grow at an 8.54% CAGR through 2032, supported by infrastructure investment, aging populations, and domestic manufacturing.

Page last updated on: